Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
Business Model:
Revenue: $0
Employees: 0-0
Address: -
City: Copenhagen
State: capital region
Zip: -
Country: DK
Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2022 | Seed | $4M |
Novo Holdings A/S Sound Bioventures |
11/2022 | Pre Seed Round | 3 | - |
Vaekstfonden Innovation Fund Denmark BioInnovation Institute Vaekstfonden Innovation Fund Denmark BioInnovation Institute |
11/2022 | Seed Round | $0 |
Novo Holdings Sound Bioventures Novo Holdings Sound Bioventures |
11/2022 | Seed Round | 2 | $4M |
Novo Holdings Sound Bioventures Novo Holdings Sound Bioventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|